AU Patent

AU2009305472B2 — Combination of an insulin and a GLP-1 agonist

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2013-12-19 · 12y expired

What this patent protects

The invention relates to a drug comprising at least one insulin and at least one GLP-1 receptor agonist.

USPTO Abstract

The invention relates to a drug comprising at least one insulin and at least one GLP-1 receptor agonist.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009305472B2
Jurisdiction
AU
Classification
—
Expires
2013-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.